In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

Hannah Pittock uses weight-loss company Novo Nordisk’s offer to acquire Metsera to create a three-prong framework by which the antitrust agencies can identify when an invitation to exclude a rival from a market constitutes illegal exclusionary conduct under Section 2 of the Sherman Act.

Steve Salop explores the anticompetitive innovation behind weight-loss giant Novo Nordisk’s offer to acquire Metsera. Novo’s proposed contract presents a new tactic by which firms with market power can preclude rival mergers that will lead to procompetitive entry.

President Donald Trump has, across two administrations, sought to lower drug prices for Americans, most recently with executive order “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Margherita Colangelo explains why his order is unlikely to accomplish its goal.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

Hamid Mehran proposes funded deferred pay, an incentive structure to mitigate the risk and costs of police misconduct. To be sure, police are doing a...

A new paper documents how LAPD officers responded to two police reforms—one in 1998 and one in late 2002. It finds that when public...

A new study looks into how Trump's 2016 presidential campaign affected police behavior toward Black Americans and finds that the probability that a Black...

Government proponents of prison labor should be mindful of the potential for negative effects, including increased incarceration rates and citizens’ deteriorating views on state...

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.

In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.

China has enacted a new competition policy that seeks to boost innovation by stifling cutthroat price competition. Padding companies’ margins will enable collusion and regulatory capture rather than innovation, write Victor Jiawei Zhang and Yahui Song.

Online degrees are reshaping higher education by lowering tuition prices and reducing in-person program availability. In new research, Nano Barahona, Cauê Dobbin, and Sebastián Otero find that Brazil’s high online enrollment benefits those who need cheaper and more flexible options, but ultimately hurts young undergraduate students who are shifting away from higher-value in-person education options.

Matt Lucky reviews Jonathan D. Cohen’s new book, Losing Big: America's Reckless Bet on Sports Gambling.